Psychosis from a Bath Salt Product Containing Flephedrone and MDPV with Serum, Urine, and Product Quantification

Abstract

Introduction The use of designer drugs commonly marketed as bath salts or plant food has risen dramatically in recent years. Several different synthetic cathinones have been indentified in these products, including mephedrone, 3,4-methylenedioxypyrovalerone (MDPV), and 4-fluoromethcathinone (flephedrone). We report a case of bath salt intoxication with quantitative MDPV and flephedrone levels in a patient's serum and urine, and from the bath salt product. Case Report A 23-year-old male with a prior psychiatric history arrived via EMS for bizarre behavior, suicidality, and hallucinations after reportedly insufflating a bath salt. He was found to have MDPV levels of 186 and 136 ng/mL in his serum and urine, respectively, and flephedrone levels of 346 and 257 ng/mL in the serum and urine, respectively. The white powder in question was found to contain 143 μg MDPV and 142 μg flephedrone per milligram powder. His psychosis and agitation resolved with lorazepam, droperidol, and observation in the emergency department.Discussion Agitation, psychosis, movement disorders, tachycardia, and hypertension have all been attributed to the use of MDPV; there are no prior reports detailing clinical experience with flephedrone. Considering that our patient's serum flephedrone levels were twofold higher than his MDPV level, it is likely flephedrone contributed to his clinical toxicity. This case suggests the possibility that fluorinated cathinones, such as flephedrone, may have altered metabolism and/or elimination which may affect their course of clinical toxicity. This case highlights the evolving composition of synthetic cathinones found in bath salt products.

‘Designer drugs’: update on the management of novel psychoactive substance misuse in the acute care setting

“…Although successful use of antidopaminergic drugs such as droperidol has been reported in patients with signifi cant hallucinations and psychosis, benzodiazepines should remain the mainstay of treatment due to the risk of precipitating neuroleptic malignant syndrome. 16 …”

The Psychoactive Designer Drug and Bath Salt Constituent MDPV Causes Widespread Disruption of Brain Functional Connectivity

“…Acute intoxication produces typical stimulant-like effects, including increased energy, euphoria, and elevated feelings of empathy, and sociability. The 'crash' that follows involves negative affective states, such as depression, suicidal thoughts, anxiety, panic attacks, excited delirium, bouts of violent aggression towards self and others, and combativeness (Haiken, 2012;Penders and Gestring, 2011;Stevenson and Tuddenham, 2014;Stoica and Felthous, 2013;Thornton et al, 2012), that resemble a severe psychotic episode (John et al, 2014). The neurobiological mechanisms that contribute to the initial positive effects are an active area of preclinical research (Bonano et al, 2014;Watterson et al, 2012); however, factors contributing to the postreward crash are unclear.…”

Potential Drug Interactions Between cART and New Psychoactive Substances

“…There also have been reports about malignant hyperthermia, rhabdomyolysis, renal failure and stroke [18][19][20][21]. 108 fatal casualties have been reported in the EU until 2014 in relation to the use of MDPV [22].…”